Circulating tumour cell gene expression and chemosensitivity analyses: predictive accuracy for response to multidisciplinary treatment of patients with unresectable refractory recurrent rectal cancer or unresectable refractory colorectal cancer liver metastases

BACKGROUND: Patients with unresectable recurrent rectal cancer (RRC) or colorectal cancer (CRC) with liver metastases, refractory to at least two lines of traditional systemic therapy, may receive third line intraarterial chemotherapy (IC) and targeted therapy (TT) using drugs selected by chemosensi...

Descripción completa

Detalles Bibliográficos
Autores principales: Guadagni, Stefano, Masedu, Francesco, Fiorentini, Giammaria, Sarti, Donatella, Fiorentini, Caterina, Guadagni, Veronica, Apostolou, Panagiotis, Papasotiriou, Ioannis, Parsonidis, Panagiotis, Valenti, Marco, Ricevuto, Enrico, Bruera, Gemma, Farina, Antonietta R., Mackay, Andrew R., Clementi, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9202660/
https://www.ncbi.nlm.nih.gov/pubmed/35710393
http://dx.doi.org/10.1186/s12885-022-09770-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9202660/
https://www.ncbi.nlm.nih.gov/pubmed/35710393
http://dx.doi.org/10.1186/s12885-022-09770-3

Ejemplares similares